Nexalin Technology (NXL) EBIT (2021 - 2026)
Nexalin Technology's (NXL) quarterly EBIT came in at -$2.1 million in Q1 2026, down 5.4% year-on-year from -$2.2 million in Q1 2025, and up 12.15% quarter-over-quarter from -$2.4 million in Q4 2025.
Nexalin Technology (NXL) EBIT (2021 - 2026) Analysis & Trends
Nexalin Technology's EBIT history runs 6 years deep, the most recent figure standing at -$2.1 million for Q1 2026.
- On a quarterly basis, EBIT fell 5.4% year-over-year to -$2.1 million in Q1 2026; TTM through Mar 2026 was -$8.5 million, a 2.22% increase from a year earlier, with the FY2025 full-year figure at -$8.4 million, down 8.2% from the prior year.
- EBIT improved to -$2.1 million in Q1 2026 per NXL's latest filing, from -$2.4 million in the prior quarter.
- Across five years, EBIT topped out at -$293194.0 in Q3 2022 and bottomed at -$2.9 million in Q4 2024.
- The 5-year median for EBIT is -$1.6 million (2025), against an average of -$1.5 million.
- Across the five-year window, EBIT soared 83.67% in 2022 and tumbled 723.87% in 2023, its largest moves.
- Year by year, EBIT stood at -$719617.0 in 2022, then sank by 125.74% to -$1.6 million in 2023, then sank by 77.0% to -$2.9 million in 2024, then gained by 16.08% to -$2.4 million in 2025, then gained by 12.15% to -$2.1 million in 2026.
- Per Business Quant, the three latest NXL EBIT figures stand at -$2.1 million (Q1 2026), -$2.4 million (Q4 2025), and -$2.3 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | -2.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.12 Mn |
| Dec 31, 2025 | -2.41 Mn |
| Sep 30, 2025 | -2.35 Mn |
| Jun 30, 2025 | -1.62 Mn |
| Mar 31, 2025 | -2.01 Mn |
| Dec 31, 2024 | -2.88 Mn |
| Sep 30, 2024 | -2.51 Mn |
| Jun 30, 2024 | -1.30 Mn |
| Mar 31, 2024 | -1.07 Mn |
| Dec 31, 2023 | -1.62 Mn |
| Sep 30, 2023 | -2.42 Mn |
| Jun 30, 2023 | -876,860.00 |
| Mar 31, 2023 | -779,426.00 |
| Dec 31, 2022 | -719,617.00 |
| Sep 30, 2022 | -293,194.00 |
| Jun 30, 2022 | -445,103.00 |
| Mar 31, 2022 | -375,117.00 |
| Dec 31, 2021 | -577,489.00 |
| Sep 30, 2021 | -1.80 Mn |